Elsevier

Gynecologic Oncology

Volume 56, Issue 2, February 1995, Pages 250-254
Gynecologic Oncology

Regular Article
The Effect of Naproxen on Fever in Patients with Advanced Gynecologic Malignancies

https://doi.org/10.1006/gyno.1995.1041Get rights and content

Abstract

The antipyretic action of naproxen has been reported as sufficiently selective for neoplasm-related fever such that the use of this agent has been recommended to distinguish neoplastic from infectious fever. The antipyretic effect of naproxen was evaluated in gynecologic oncology patients with advanced pelvic malignancies and fever without obvious source of infection (suspected neoplastic fever). Naproxen (250 mg orally every 8 hr) was given to 12 patients with (i) a daily temperature greater than 38.3°C, (ii) fever for at least 3 days, (iii) no evidence of infection on physical exam, (iv) negative results of blood and urine cultures, and (v) a chest roentgenogram negative for pneumonia. Ten of the 12 patients initially received a minimum of 3 days of empiric antibiotic therapy without resolution of fever. Within 24 hr of starting naproxen therapy, 10 patients' (83%) fever responded: Eight patients (80%) had a complete lysis of fever and two had partial lysis (20%). Temperature response was accompanied by subjective improvement in patient malaise and fatigue. Naproxen therapy was continued for 5-7 days in these patients, and chemotherapy was administered to those patients scheduled to receive it. Two patients did not respond to naproxen therapy in 24 hr; thus, it was stopped and the fever workup was continued. Of these two patients, one was eventually diagnosed with bacteremia after multiple negative blood cultures and initially no response to antibiotics. Naproxen is clinically useful in the palliation of fever-related symptoms in gynecologic oncology patients with suspected neoplastic fever. Naproxen may also allow the limitation of extensive fever workups and prolonged empiric antibiotic therapy in these patients, and prevent delays in systemic therapy or supportive care.

References (0)

Cited by (11)

  • Using vital sign flow sheets can help to identify neoplastic fever and other possible causes in oncology patients: A retrospective observational study

    2010, Journal of Pain and Symptom Management
    Citation Excerpt :

    Nonsteroidal anti-inflammatory drugs (NSAIDs), such as naproxen or indomethacin, are effective in ameliorating the NF.8–12 The naproxen test is a clinical tool in the differential diagnosis of fever of undetermined origin in cancer patients.1,2,8–13 The standard test of naproxen dose is 500 mg every 12 hours for two days.

  • Neoplastic fever caused by lung cancer

    2007, Journal of Thoracic Oncology
  • Lack of value of the naproxen test in the differential diagnosis of prolonged febrile illnesses

    2003, American Journal of Medicine
    Citation Excerpt :

    The ultimate diagnosis was diffuse non-Hodgkin's lymphoma with cerebral involvement. Based on several studies involving febrile cancer patients, naproxen has been proposed as an aid in the differential diagnosis of FUO because its antipyretic effect has been presumed to be specific for neoplastic fever (1–7). However, the relevance of the effects of NSAIDs in febrile cancer patients to the workup of patients with a FUO is uncertain.

View all citing articles on Scopus
View full text